Lung Cancer — Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
Citation(s)
A Phase II Trial of Concurrent Docetaxel (Taxotere) / Carboplatin / Radiotherapy Followed by Surgical Resection Followed by Consolidation Taxotere / Carboplatin in Stage III Non-Small Cell Lung Cancer (NSCLC)